Ignite Creation Date:
2024-05-06 @ 9:30 AM
Last Modification Date:
2024-10-26 @ 12:15 PM
Study NCT ID:
NCT02990845
Status:
TERMINATED
Last Update Posted:
2023-02-22
First Post:
2016-12-01
Brief Title:
Pembrolizumab and Exemestane Leuprolide in Premenopausal HR HER2- Locally Advanced or Metastatic Breast Cancer
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-16
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-01
First Submit QC Date:
December 8 2016
Study First Post Date:
2016-12-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-20
Last Update Post Date:
2023-02-22
Last Update Post Date Type:
ACTUAL